1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
Pilot Projects Investigating Understudied Proteins Associated with Rare Diseases (R03 Clinical Trial Not Allowed) is sponsored by National Center for Advancing Translational Sciences (NCATS)/National Institutes of Health (NIH). This R03 grant supports pilot projects that investigate understudied proteins associated with rare diseases.
Leukodystrophies are rare diseases, and research into the proteins involved in their pathogenesis would be highly relevant.
Get alerted about grants like this
Save a search for “National Center for Advancing Translational Sciences (NCATS)/National Institutes of Health (NIH)” or related topics and get emailed when new opportunities appear.
Search similar grants →According to the current listing, eligibility includes: Academic and research institutions are typically eligible for NIH R03 grants. This program supports early-stage research. Confirm the full requirements in the official notice before applying.
The published deadline was June 16, 2026, which has passed. Check the official notice for any future application windows before investing time in a proposal.
Pilot Projects Investigating Understudied Proteins Associated with Rare Diseases (R03 Clinical Trial Not Allowed) is funded by National Center for Advancing Translational Sciences (NCATS)/National Institutes of Health (NIH). Verify program details on the funder's official page before applying.
Start from the official opportunity page linked in this listing — it carries the sponsor's submission instructions.
Past winners and funding trends for this program
Advance from NIH SBIR Phase I to Phase II with tips on demonstrating feasibility, building a commercialization plan, and securing $1M in funding.
Read articleNIH's June 1 omnibus reset added Direct-to-Phase II to the STTR program for the first time. The change compresses university spinouts' funding timeline from three years to fifteen months, but the 30% research-institution subaward, feasibility-evidence rules, and IP licensing mechanics are not yet sorted at most universities.
Read articleNIH committed $402 million across 601 multiyear-funded grants in the first eight months of FY 2026 — more than four times the pace of two years ago. The mechanism front-loads obligations into a single fiscal year, leaving less budget for new project starts and squeezing FY 2026 success rates. What researchers and institutions should be doing now.
Read article